Friday, 22 Jun 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Olga Petryna at EULAR 2018 -...

20 Jun 2018

RWCS 2017: An Interesting Case of...

21 Feb 2017

Dr. Anna Postolova: MTX in the...

11 Feb 2018

The RheumNow Week in Review – 7 April...

07 Apr 2017

The RheumNow Week in Review – 24...

24 Feb 2017

The RheumNow Week in Review – 31 March...

31 Mar 2017

Dr. Paul Sufka: Rheumatology Journal...

05 Nov 2017

Dr. Olga Petryna at EULAR2018 Discusses...

15 Jun 2018

Dr. Bernie Rubin: Fellows Program at...

09 Feb 2018

The RheumNow EULAR Week in Review – 16...

16 Jun 2017

RheumNow Week in Review – 14 October...

14 Oct 2016

Dr. Philip Robinson at EULAR 2018 on...

20 Jun 2018